Re: Four new drugs added to QTdrugs.org Lists on March 29, 2019
The following drugs have been added to the list of drugs with a Possible Risk of Torsades de pointes (TdP) because AZCERT's Scientific Review Committee has found evidence of QT prolongation with their use but, at this time, found no convincing evidence of TdP.
Cobimetinib (Anti-cancer drug) Brand name: Citellic®
Ivosidenib (Anti-cancer drug) Brand name: Tibsovo®
Gilteritinib (Anti-cancer drug) Brand name: Xospata®
Alimemazine (An antihistamine available in the UK also known as trimeprazine) Numerous brand names available